IGF1 and muscle atrophy: Furthermore, CRISPR-SAM was employed to stimulate the expression of multiple IGF1 gene isoforms in human and mouse myoblasts in vitro, which facilitated myogenic differentiation and may prove beneficial for muscle atrophy therapy [194].